Zobrazeno 1 - 10 of 506 pro vyhledávání: '"Sanchez Gonzalez Y"'
1
Akademický článek
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons.
Autor: Reinisch W; Department Internal Medicine III, Division Gastroenterology & Hepatology, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. walter.reinisch@meduniwien.ac.at., Melmed GY; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Seidelin J; Department of Gastroenterology and Hepatology, Copenhagen University Hospital-Gentofte and Herlev, Herlev, Denmark., Ma C; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.; Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada., Xuan S; AbbVie Inc., North Chicago, IL, USA., Tran J; AbbVie Inc., North Chicago, IL, USA.; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA., Remple V; AbbVie Inc., North Chicago, IL, USA., Wegrzyn L; AbbVie Inc., North Chicago, IL, USA., Levy G; AbbVie Inc., North Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie Inc., North Chicago, IL, USA., Panaccione R; Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
Publikováno v: Advances in therapy [Adv Ther] 2024 Oct; Vol. 41 (10), pp. 3832-3849. Date of Electronic Publication: 2024 Aug 10.
Zobrazit plný text záznamu
2
Akademický článek
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Autor: Louis E; Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital CHU of Liège, Liège, Belgium., Schreiber S; Department of Internal Medicine, University Hospital Schleswig-Holstein, Christian-Albrecht University of Kiel, Kiel, Germany., Panaccione R; Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada., Bossuyt P; Imelda GI Clinical Research Center, Imelda General Hospital, Bonheiden, Belgium., Biedermann L; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland., Colombel JF; Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Parkes G; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, England., Peyrin-Biroulet L; Department of Gastroenterology and INSERM U1256, University Hospital of Nancy, Lorraine University, Vandoeuvre, France., D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka, Japan., Siegmund B; Department of Gastroenterology, Infectiology and Rheumatology, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Wu K; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China., Boland BS; Division of Gastroenterology, University of California-San Diego, La Jolla., Melmed GY; F. Widjaja Inflammatory Bowel Disease Institute, Cedars Sinai Medical Center, Los Angeles, California., Armuzzi A; IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Levine P; AbbVie Inc, North Chicago, Illinois., Kalabic J; AbbVie Deutschland GmbH and Co KG, Ludwigshafen, Germany., Chen S; AbbVie Inc, North Chicago, Illinois., Cheng L; AbbVie Inc, North Chicago, Illinois., Shu L; AbbVie Inc, North Chicago, Illinois., Duan WR; AbbVie Inc, North Chicago, Illinois., Pivorunas V; AbbVie Inc, North Chicago, Illinois., Sanchez Gonzalez Y; AbbVie Inc, North Chicago, Illinois., D'Cunha R; AbbVie Inc, North Chicago, Illinois., Neimark E; AbbVie Inc, North Chicago, Illinois., Wallace K; AbbVie Inc, North Chicago, Illinois., Atreya R; First Department of Medicine, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany., Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Publikováno v: JAMA [JAMA] 2024 Sep 17; Vol. 332 (11), pp. 881-897.
Zobrazit plný text záznamu
3
Akademický článek
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease.
Autor: Louis E; University of Liège, Liège, Belgium. Edouard.Louis@ulg.ac.be., Lee WJ; AbbVie Inc, Chicago, IL, USA., Litcher-Kelly L; Adelphi Values, Boston, MA, USA., Ollis S; Adelphi Values, Boston, MA, USA., Pranschke E; Adelphi Values, Boston, MA, USA., Fitzgerald K; AbbVie Inc, Chicago, IL, USA., Lacerda AP; AbbVie Inc, Chicago, IL, USA., Neimark E; AbbVie Inc, Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie Inc, Chicago, IL, USA., Panés J; Hospital Clínic de Barcelona, Barcelona, Spain.
Publikováno v: Advances in therapy [Adv Ther] 2024 Sep; Vol. 41 (9), pp. 3678-3705. Date of Electronic Publication: 2024 Aug 06.
Zobrazit plný text záznamu
5
Akademický článek
Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment
Autor: Abou Rached A, Abou Kheir S, Saba J, Assaf S, Kassis G, Sanchez Gonzalez Y, Ethgen O
Publikováno v: Hepatic Medicine: Evidence and Research, Vol Volume 10, Pp 73-85 (2018)
Antoine Abou Rached,1 Selim Abou Kheir,1 Jowana Saba,1 Salwa Assaf,2 Georges Kassis,3 Yuri Sanchez Gonzalez,4 Olivier Ethgen5,6 1Faculty of Medicine, School of Medicine, Lebanese University, Beirut, Lebanon; 2Abbvie Biopharmaceuticals GmbH, Beirut, L
Externí odkaz: https://doaj.org/article/8739804e6ef54baf9f625f6318463cce
Zobrazit plný text záznamu
6
Akademický článek
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.
Autor: Saruta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Kawaguchi I; AbbVie GK, Tokyo, Japan., Ogawa Y; AbbVie GK, Tokyo, Japan., Sanchez Gonzalez Y; AbbVie Inc., North Chicago, IL, USA., Numajiri N; AbbVie GK, Tokyo, Japan., Tang X; Syneos Health, Tokyo, Japan., Miller R; Syneos Health, Tokyo, Japan.
Publikováno v: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 566-574. Date of Electronic Publication: 2024 Apr 05.
Zobrazit plný text záznamu
7
Akademický článek
A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index.
Autor: Peyrin-Biroulet L; University Hospital of Nancy-Brabois, Vandoeuvre-lès-Nancy, France., Arenson E; Adelphi Values, Boston, MA, USA., Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA., Siegel CA; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Lee S; University of Washington Medical Center, Seattle, WA, USA., Stephen Laroux F; AbbVie Bioresearch Center, Worcester, MA, USA., Zhou W; AbbVie Inc., Chicago, IL, USA., Finney-Hayward T; AbbVie Ltd, Maidenhead, UK., Sanchez Gonzalez Y; AbbVie Inc., Chicago, IL, USA., Shields AL; Adelphi Values, Boston, MA, USA.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2023 Nov 24; Vol. 17 (11), pp. 1733-1743.
Zobrazit plný text záznamu
8
Akademický článek
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Autor: Danese S; Gastroenterology and Digestive Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy., Tran J; Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA.; AbbVie Inc, Chicago, IL, USA., D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Rubin DT; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA., Aoyama N; Department of Gastroenterology, Gastrointestinal Endoscopy and IBD Center, Aoyama Medical Clinic, Kobe, Japan., Zhou W; AbbVie Inc, Chicago, IL, USA., Ilo D; AbbVie Inc, Chicago, IL, USA., Yao X; AbbVie Inc, Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie Inc, Chicago, IL, USA., Panaccione R; Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2023 Nov 02; Vol. 29 (11), pp. 1723-1729.
Zobrazit plný text záznamu
9
Akademický článek
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study.
Autor: Vermeire S; Department of Gastroenterology & Hepatology, University Hospital Leuven, Leuven, Belgium. Electronic address: severine.vermeire@uzleuven.be., Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy., Zhou W; AbbVie, North Chicago, IL, USA., Ilo D; AbbVie, North Chicago, IL, USA., Klaff J; AbbVie, North Chicago, IL, USA., Levy G; AbbVie, North Chicago, IL, USA., Yao X; AbbVie, North Chicago, IL, USA., Chen S; AbbVie, North Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie, North Chicago, IL, USA., Hébuterne X; Department of Gastroenterology and Clinical Nutrition, CHU de Nice, Université Côte d'Azur, Nice, France., Lindsay JO; Department of Gastroenterology, The Royal London Hospital, Barts Health NHS Trust, London, UK., Higgins PDR; Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA., Cao Q; Department of Gastroenterology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China., Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA., Panaccione R; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
Publikováno v: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Nov; Vol. 8 (11), pp. 976-989. Date of Electronic Publication: 2023 Sep 09.
Zobrazit plný text záznamu
10
Akademický článek
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.
Autor: Parkes G; Dept of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK. gareth.parkes@nhs.net., Ungaro RC; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy., Abreu MT; Division of Gastroenterology, Crohn's and Colitis Center, University of Miami Miller School of Medicine, Miami, FL, USA., Arenson E; Adelphi Values, Boston, MA, USA., Zhou W; AbbVie Inc., Chicago, IL, USA., Ilo D; AbbVie Inc., Chicago, IL, USA., Laroux FS; AbbVie Bioresearch Center, Worcester, MA, USA., Deng H; AbbVie Inc., Chicago, IL, USA.; Department of Pharmacy Systems Outcomes and Policy, University of Illinois at Chicago, Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie Inc., Chicago, IL, USA., Peyrin-Biroulet L; University Hospital of Nancy, Lorraine University, Vandoeuvre, France.
Publikováno v: Journal of gastroenterology [J Gastroenterol] 2023 Oct; Vol. 58 (10), pp. 990-1002. Date of Electronic Publication: 2023 Jul 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje